We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 431 results
  1. Atypical lobular hyperplasia: what we need to know

    Atypical lobular hyperplasia (ALH) is defined as an epithelial proliferation that does not meet the qualitative or quantitative abnormalities to be...

    Romuald Ferre, Cherie M. Kuzmiak in Journal of Medical Imaging and Interventional Radiology
    Article Open access 12 June 2024
  2. Upgrade Rate and Long-term Outcomes of Lobular Neoplasia

    Purpose of Review

    Lobular neoplasia is a risk factor for breast cancer development, but its management remains controversial as upgrade rates differ...

    Sara Ardila, Annabel Chen, ... April Phantana-angkool in Current Breast Cancer Reports
    Article 31 January 2024
  3. Atypical Lobular Hyperplasia and Classic Lobular Carcinoma In Situ Can Be Safely Managed Without Surgical Excision

    Background

    Based on modern series demonstrating low upgrade rates for pure lobular neoplasia (LN) diagnosed on core needle biopsy (CNB), our...

    Alison Laws, Fisher Katlin, ... Tari A. King in Annals of Surgical Oncology
    Article 23 September 2021
  4. De-escalation of Surgical Intervention and Contemporary Management Recommendations for Lobular Neoplasia, Atypical Ductal Hyperplasia, and Ductal Carcinoma In Situ

    Purpose of Review

    In which patients is it oncologically safe to offer active surveillance instead of surgery for DCIS or a benign breast lesion with...

    Amanda L. Amin, Megan E. Miller in Current Breast Cancer Reports
    Article 04 May 2023
  5. Risk of Lobular Neoplasia Upgrade with Synchronous Carcinoma

    Background

    Atypical lobular hyperplasia (ALH) and classic lobular carcinoma in situ encompass a spectrum of proliferative lesions known as lobular...

    Isabelle L. Crary, Elizabeth U. Parker, ... Meghan R. Flanagan in Annals of Surgical Oncology
    Article 08 July 2022
  6. The Influence of Body Mass Index on the Histopathology and Outcomes of Patients Diagnosed with Atypical Breast Lesions

    Background

    Multiple studies have demonstrated a link between obesity and breast cancer; however, the potential association between obesity and...

    Krislyn N. Miller, Samantha M. Thomas, ... Jennifer K. Plichta in Annals of Surgical Oncology
    Article 11 August 2022
  7. The morphologic spectrum of lobular carcinoma in situ (LCIS) observations on clinical significance, management implications and diagnostic pitfalls of classic, florid and pleomorphic LCIS

    Lobular carcinoma in situ (LCIS) is a non-invasive proliferation of atypical dyscohesive epithelial cells characterized by loss or functional...

    Edi Brogi in Virchows Archiv
    Article 14 May 2022
  8. Determination of Factors Associated with Upstage in Atypical Ductal Hyperplasia to Identify Low-Risk Patients Where Active Surveillance May be an Alternative

    Background

    Excision is routinely recommended for atypical ductal hyperplasia (ADH) found on core biopsy given cancer upstage rates of near 20%....

    Alexandra J. E. Greene, Joshua Davis, ... Christine Dauphine in Annals of Surgical Oncology
    Article Open access 22 February 2024
  9. Current Perspectives on Lobular Neoplasia of the Breast

    Purpose of Review

    To present current data on histopathologic types, imaging presentation, and management of lobular neoplasia of the breast.

    ...
    Mirelys Barrios, Barbara Susnik, Fernando Collado-Mesa in Current Radiology Reports
    Article 15 December 2022
  10. Atypical lobular hyperplasia on core needle biopsy: contemporary results from a large community hospital breast program

    Purpose

    The management of biopsy proven atypical lobular hyperplasia (ALH) is controversial. Although upgrade rates are low, excisional biopsy is...

    Dean Lumley, Deidre Stokes, ... Johnny Kao in Breast Cancer Research and Treatment
    Article 23 July 2020
  11. Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy: Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management

    Objective

    The aim of this study was to determine surgical and clinical outcomes of lobular neoplasia (LN) diagnosed by magnetic resonance imaging...

    Shlermine A. Everidge, Jia Sun, ... Puneet Singh in Annals of Surgical Oncology
    Article 20 December 2023
  12. High-risk lesions in the breast diagnosed by MRI-guided core biopsy: upgrade rates and features associated with malignancy

    Purpose

    This study assessed the upgrade rates of high-risk lesions (HRLs) in the breast diagnosed by MRI-guided core biopsy and evaluated imaging and...

    Eumee Cha, Emily B. Ambinder, ... Kelly S. Myers in Breast Cancer Research and Treatment
    Article 15 October 2022
  13. Immediate and delayed risk of breast cancer associated with classic lobular carcinoma in situ and its variants

    Objective

    To determine the risk of breast cancer due to lobular carcinoma in situ (LCIS).

    Methods

    This retrospective IRB-approved study identified...

    Hannah L. Chung, Lavinia P. Middleton, ... Gary J. Whitman in Breast Cancer Research and Treatment
    Article 12 March 2024
  14. High-Risk Breast Lesions Diagnosed by Ultrasound-Guided Vacuum-Assisted Excision

    Purpose

    The aim of this study was to analyze the role of ultrasound-guided vacuum-assisted excision (US-guided VAE) in the treatment of high-risk...

    ** He, Yu-Tao Lei, ... Li-Gang Cui in World Journal of Surgery
    Article 08 February 2023
  15. Screening MRI Does Not Increase Cancer Detection or Result in an Earlier Stage at Diagnosis for Patients with High-Risk Breast Lesions: A Propensity Score Analysis

    Background

    Guidelines recommend consideration of screening MRI for patients with high-risk breast lesions (HRLs), acknowledging limited data for this...

    Alison Laws, Fisher Katlin, ... Tari A. King in Annals of Surgical Oncology
    Article 28 September 2022
  16. The lobular neoplasia enigma: management and prognosis in a long follow-up case series

    Background

    Many oncologists debate if lobular neoplasia (LN) is a risk factor or an obligatory precursor of more aggressive disease. This study has...

    Jasna Metovic, Simona Osella Abate, ... Isabella Castellano in World Journal of Surgical Oncology
    Article Open access 18 March 2021
  17. High-risk and selected benign breast lesions diagnosed on core needle biopsy: Evidence for and against immediate surgical excision

    The vast majority of image-detected breast abnormalities are diagnosed by percutaneous core needle biopsy (CNB) in contemporary practice. For frankly...

    Aparna Harbhajanka, Hannah L. Gilmore, Benjamin C. Calhoun in Modern Pathology
    Article 02 June 2022
  18. Lobular carcinoma in situ: diagnostic criteria and molecular correlates

    Lobular neoplasia (LN) is an atypical proliferation of small, dyscohesive epithelial cells within the terminal duct lobular unit (TDLU), with or...

    Anna Sokolova, Sunil R. Lakhani in Modern Pathology
    Article 06 October 2020
  19. Upgrade Rates and Breast Cancer Development Among Germline Pathogenic Variant Carriers with High-Risk Breast Lesions

    Background

    High-risk lesions (HRL) of the breast are risk factors for future breast cancer development and may be associated with a concurrent...

    Alison Laws, Saskia Leonard, ... Melissa L. Pilewskie in Annals of Surgical Oncology
    Article 23 January 2024
  20. Radiologic and Pathologic Correlation of Invasive Lobular Carcinoma of the Breast

    Purpose of Review

    The primary goal of this review is to give an update on the radiologic and pathologic features of invasive lobular carcinoma (ILC),...

    Eniola Oluyemi, Ani Peshtani, ... Ashley Cimino-Mathews in Current Breast Cancer Reports
    Article 27 October 2021
Did you find what you were looking for? Share feedback.